# US 2021/0171575 A1 · Solution phase routes for wnt hexapeptides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0171575 A1
- Document ID: US20210171575A1
- Status: Published application
- Kind: A1
- Application number: 17/267,764
- Filed: 2019-08-19
- Published: 2021-06-10
- Earliest claimed: 2018-08-20
- Assignees: Wntresearch AB
- Applicants: Wntresearch AB
- Inventors: Dennis HENRIKSEN
- Web page: https://patentgrep.com/patent/US20210171575A1

## CPC

- C07K 7/06: having 5 to 11 amino acids
- C07K 5/081: {the side chain containing O or S as heteroatoms, e.g. Cys, Ser}
- C07K 14/47: from mammals
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The present disclosure relates generally to the field of polypeptide synthesis, and more particularly, to the solution phase synthesis of the Wnt hexapeptide Foxy-5 and protected derivatives and peptide fragments thereof.

## Claims

### Claim 1

A protected peptide fragment of Foxy-5 (For-Met-Asp-Gly-Cys-Glu-Leu-OH) selected from
a. PG1-Gly-Cys(PG2)-Glu(OPG3)-Leu-OR1
b. PG1-Asp(OPG3)-Gly-Cys(PG2)-Glu(OPG3)-Leu-OR1
c. PG1-Met-Asp(OPG3)-Gly-Cys(PG2)-Glu(OPG3)-Leu-OR1
d. For-Met-Asp(OPG3)-Gly-Cys(PG2)-Glu(OPG3)-Leu-OR1,
wherein PG1 is selected from H and base sensitive protecting groups such as fluorenylmethyl-oxycarbonyl (Fmoc), PG2 is selected from H and trityl (Trt), PG3 is selected from H and Cert-butyl (tBu), and R1 is chosen from H and C1-C6 alkyl, such as methyl, ethyl or Cert-butyl (tBu) with the proviso that PG1, PG2, PG3 and R1 are not simultaneously hydrogen.

### Claim 2 (depends on 1)

The protected peptide fragment of Foxy-5 (For-Met-Asp-Gly-Cys-Glu-Leu-OH) according to claim 1, selected from
a. Fmoc-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu (SEQ_ID NO 6),
b. Fmoc-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu (SEQ_ID NO 3)
c. Fmoc-Met-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu(SEQ_ID NO 4)
d. For-Met-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu (SEQ_ID NO 15).

### Claim 3 (depends on 1)

The protected tetrapeptide fragment of Foxy-5 according to claim 1 in solid form.

### Claim 4 (depends on 1)

The protected tetrapeptide fragment of Foxy-5 according to claim 1 in crystalline form.

### Claim 5

A solution phase method for preparing a protected derivative of Foxy-5, PG1-Met-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu, the method comprising:
a. Sequentially coupling tripeptide Fmoc-Cys(Trt)Glu(OtBu)-Leu-OtBu (KT-2*) with Fmoc-Gly-OH, Fmoc-Asp-OtBu and PG1-Met, or
b. Sequentially coupling tetrapeptide Fmoc-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu (SEQ_ID NO 6) with Fmoc-Asp-OtBu and PG1-Met,
wherein
i. Fmoc deprotection is achieved with DBU, and wherein
ii. DBU is removed from the reaction mass before coupling with Fmoc-Asp-OtBu, and wherein
iii. PG1 is a base sensitive protecting group such as Fmoc.

### Claim 6

A solution phase method for converting PG1-Met-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu to Foxy-5 (For-Met-Asp-Gly-Cys-Glu-Leu-OH), the method comprising:
i. Removal of PG1 from hexapeptide PG1-Met-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu followed by coupling with formic acid to yield For-Met-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu (SEQ_NO 15),
ii. Deprotection of For-Met-Asp(OtBu)-Gly-Cys(Trt)-Glu(OtBu)-Leu-OtBu (SEQ_NO 15) to afford Foxy-5 in crude form,
followed by:
a. Optional purification of the crude product by column chromatography, optionally followed by precipitation as a solid from an organic solvent,
b. Optional precipitation of the formed Foxy-5 hexapeptide as an alkaline or acidic salt in solid form, such as in crystalline form.
